GlassScriptPhysician profile
Laurie Beth Waldron
NPI 1679849707
$599.74
in general payments reported to CMS, 2019-2025
16 companies · $79.17 in 2025
The $79.17 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.01 · 2022: $34.19 · 2023: $253 · 2024: $140 · 2025: $79.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $196.27 | 2021-2023 | T2 |
| Integra Lifesciences Corporation | $71.85 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Theragen, INC. | $46.25 | 2023 | Actastim-S, Kneehab Xp |
| Orthofix Medical, INC. | $39.97 | 2023-2024 | Spinal-Stim, Spinal-Stim, Physio-Stim |
| Medtronic, INC. | $37.58 | 2023-2025 | O-Arm, Unid_pass |
| Biomarin Pharmaceutical INC. | $28.72 | 2024 | Voxzogo 1.2mg |
| Impel Pharmaceuticals LLC | $20.93 | 2025 | Trudhesa |
| Baxter Healthcare | $20.10 | 2023 | Floseal |
| Smith+Nephew, INC. | $19.95 | 2024 | Pico 14 |
| Sk Life Science, INC. | $19.50 | 2021 | |
| Amgen INC. | $19.45 | 2024 | |
| Kyowa Kirin, INC. | $18.50 | 2024 | Crysvita |
| Teva Pharmaceuticals USA, INC. | $17.50 | 2021 | |
| Molnlycke Health Care US, LLC | $15.36 | 2023 | Mepilex Border Post-Op Ag, Mepilex Border Flex, Mepilex Border Sacrum |
| Supernus Pharmaceuticals, INC. | $14.57 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.